Iradimed (IRMD) Preferred Shares (2013 - 2014)
Iradimed (IRMD) posted quarterly Preferred Shares of $140.0 for Q2 2014, little changed on a QoQ basis from $140.0 in Q4 2013.
Iradimed (IRMD) Preferred Shares (2013 - 2014) Analysis & Trends
Iradimed has reported Preferred Shares for 2 years, with the latest figure at $140.0 in Q2 2014.
- Preferred Shares for Q2 2014 came in at $140.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2014 was $140.0 (changed N/A YoY), and the FY2013 annual result was $140.0, changed N/A from the prior year.
- Preferred Shares steadied at $140.0 in Q2 2014, from $140.0 in the prior quarter.
- Over five years, Preferred Shares peaked at $140.0 in Q4 2013 and troughed at $140.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | - |
| 10 | Iradimed | 1.12 Bn | 1.06 Bn | 15.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 140.00 |
| Dec 31, 2013 | 140.00 |